|
Quantum Dye® Technology |
Quantum Dye® technology has been
jointly developed by
Robert C.
Leif, Ph.D. of Newport Instruments and Professor
Lidia Vallarinoof Virginia Commonwealth University.
Quantum Dyes® are macrocycles which include a
central phosphorescent lanthanide atom - the same atoms
that are used in color television sets. These atoms
have the unique advantage of producing narrow-band,
long-lived, luminescent emissions in the wet and dry
states. Quantum Dye® luminescent labels are
uniquely sensitive because:
These characteristics of Quantum Dyes®: permit multiplexed clinical assays, result in minimal contamination of the emission spectrum of one dye by another, localized staining on slides, and have excellent signal to noise. This makes automated processing of samples easier as well as allowing multiple dyes to be combined in one sample preparation. These are all characteristics that make Quantum Dye® technology ideal for the detection and examination of rare events. |
As shown in the figure these compounds have very narrow emissions, a half-max width of 5.2 nm vs. 37.5 nm for fluorescein. The emission of europium Quantum Dye was increased by use of a lanthanide enhance luminescence solution (LEL) which contains gadolinium. The Phoenix Flow Systems' anti5-BrdU antibody has been labelled with the monoisothiocyanate version of the europium macrocycle. Modified versions of the Phoenic Flow kits have been employed to produce directly stained apoptotic and S phase cells, which are counter stained with DAPI. Please follow this link to see them. This product is for sale to investigators and colaborating companies. More information is available on the papers Newport is looking for collaborators to expand our markets to fluorescence in situ hybridization, FISH and comparative genomic hybridization. Need a sample? Then contact Newport Instruments. |
|
The diisothiocyanate of the europium Quantum Dye is commercially available from Research Organics. |
Research Organics Inc.
(800) 321-0570
|